Chronic Immune Thrombocytopenia (chronic ITP) is an autoimmune disorder in which patients produce antiplatelet autoantibodies and specialized white blood cells that destroy their blood platelets and, in some cases, damage their megakaryocytes, causing a decrease in platelet production. The global chronic immune thrombocytopenia market size was worth $ XX billion in 2019 and is forecasted to reach $ XX billion by 2026, at a CAGR of XX% during the forecast period (2019-2026).
View Full Report Sample: https://www.datamintelligence.com/research-report/chronic-immune-thrombocytopenia-market
Download free Report Sample: https://www.datamintelligence.com/download-sample/chronic-immune-thrombocytopenia-market